| 3,3'-diindolylmethane | Investigational | CYP1B1 | 1545 |
upregulated | diindolylmethane results in increased expression of CYP1B1 mRNA | 2p22.2 | |
| 3,3'-diindolylmethane | Investigational | CYP3A4 | 1576 |
upregulated | [diindolylmethane results in increased activity of NR1I2 protein] which results in increased expression of CYP3A4 mRNA | 7q22.1 | |
| 3,3'-diindolylmethane | Investigational | CYP3A4 | 1576 |
upregulated | diindolylmethane results in increased expression of CYP3A4 mRNA | 7q22.1 | |
| Diltiazem | Approved Investigational | IL12A | 3592 |
downregulated | Diltiazem results in decreased expression of IL12A mRNA | 3q25.33 | |
| Diltiazem | Approved Investigational | IL12B | 3593 |
downregulated | Diltiazem results in decreased expression of IL12B mRNA | 5q33.3 | |
| N,N-dimethylformamide | Experimental | LTF | 4057 |
upregulated | Dimethylformamide results in increased expression of LTF mRNA | 3p21.31 | |
| N,N-dimethylformamide | Experimental | MPO | 4353 |
upregulated | Dimethylformamide results in increased expression of MPO mRNA | 17q22 | |
| N,N-dimethylformamide | Experimental | NCF1 | 653361 |
upregulated | Dimethylformamide results in increased expression of NCF1 mRNA | 7q11.23 | |
| N,N-dimethylformamide | Experimental | TNFSF10 | 8743 |
upregulated | Dimethylformamide results in increased expression of TNFSF10 mRNA | 3q26 | |
| Dimethyl fumarate | Approved Investigational | CCL2 | 6347 |
downregulated | Dimethyl Fumarate results in decreased expression of CCL2 mRNA | 17q12 | |
| Dimethyl fumarate | Approved Investigational | HMOX1 | 3162 |
upregulated | Dimethyl Fumarate results in increased expression of HMOX1 mRNA | 22q12.3 | |
| Dimethyl fumarate | Approved Investigational | ICAM1 | 3383 |
downregulated | Dimethyl Fumarate results in decreased expression of ICAM1 mRNA | 19p13.2 | |
| Dimethyl fumarate | Approved Investigational | TNF | 7124 |
downregulated | Dimethyl Fumarate results in decreased expression of TNF mRNA | 6p21.33 | |
| Dimethyl sulfoxide | Approved Investigational Vet Approved | ACTC1 | 70 |
downregulated | Dimethyl Sulfoxide results in decreased expression of ACTC1 mRNA | 15q14 | |
| Dimethyl sulfoxide | Approved Investigational Vet Approved | ACTC1 | 70 |
upregulated | Dimethyl Sulfoxide results in increased expression of ACTC1 mRNA | 15q14 | |
| Dimethyl sulfoxide | Approved Investigational Vet Approved | ALB | 213 |
downregulated | Dimethyl Sulfoxide results in decreased expression of ALB mRNA | 4q13.3 | |
| Dimethyl sulfoxide | Approved Investigational Vet Approved | APOA1 | 335 |
upregulated | Dimethyl Sulfoxide results in increased expression of APOA1 mRNA | 11q23.3 | |
| Dimethyl sulfoxide | Approved Investigational Vet Approved | BAX | 581 |
upregulated | Dimethyl Sulfoxide results in increased expression of BAX mRNA | 19q13.33 | |
| Dimethyl sulfoxide | Approved Investigational Vet Approved | CLDN6 | 9074 |
upregulated | Dimethyl Sulfoxide results in increased expression of CLDN6 mRNA | 16p13.3 | |
| Dimethyl sulfoxide | Approved Investigational Vet Approved | CLDN8 | 9073 |
upregulated | Dimethyl Sulfoxide results in increased expression of CLDN8 mRNA | 21q22.11 | |
| Dimethyl sulfoxide | Approved Investigational Vet Approved | CLDN9 | 9080 |
upregulated | Dimethyl Sulfoxide results in increased expression of CLDN9 mRNA | 16p13.3 | |
| Dimethyl sulfoxide | Approved Investigational Vet Approved | CSF1R | 1436 |
upregulated | Dimethyl Sulfoxide results in increased expression of CSF1R mRNA | 5q32 | |
| Dimethyl sulfoxide | Approved Investigational Vet Approved | CXCL8 | 3576 |
downregulated | Dimethyl Sulfoxide results in decreased expression of CXCL8 mRNA | 4q13.3 | |
| Dimethyl sulfoxide | Approved Investigational Vet Approved | CXCL8 | 3576 |
upregulated | Dimethyl Sulfoxide results in increased expression of CXCL8 mRNA | 4q13.3 | |
| Dimethyl sulfoxide | Approved Investigational Vet Approved | EDN2 | 1907 |
downregulated | Dimethyl Sulfoxide results in decreased expression of EDN2 mRNA | 1p34.2 | |